Axon Enterprise is trading 4.18% down at $431.78 as investors weigh dilution risks from its recently issued zero-coupon convertible notes.
- Recent coverage identifies the $1.15 billion convertible-note offering and valuation concerns as key pressures.
- Broader market pressure includes the Nasdaq Composite down 0.74%, while higher Treasury yields weigh on growth-stock valuations.
- No new company announcement clearly explains the sharper September 24 decline.